Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has ...

GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in the next year. In an interview at the JP Morgan Healthcare Conference in San Francisco ...

GlaxoSmithKline (GSK) appears to be focusing more on finding a new CEO than any large M&A deals after last year's $20 billion asset swap with Novartis, according to a briefing following strong Q1 ...

Anne Wojcicki has resigned as 23andMe's CEO. She is the sister of late YouTube CEO Susan Wojcicki and the ex-wife of Sergey ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

In the least surprising news of the day, 23andMe has officially filed for bankruptcy and the CEO jumped ship — with the ...

Speaking at the CEO Times Summit in London, Walmsley highlights the U.K. pharmaceutical company's refocused R&D strategy, with investments concentrated in the U.K., U.S., and Europe. GSK ...

GSK CEO Emma Walmsley is the first woman to lead a big pharmaceutical company. At an investor conference on Tuesday, she was asked about female leadership in the industry. She responded with how ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

Syngene International appoints Peter Bains as MD & CEO. Syngene International announced that its board approved the ...